Winton Group LTD Vir Biotechnology, Inc. Transaction History

Winton Group LTD

$1.35 Billion
Q1 2024

A detailed history of Winton Group LTD transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Winton Group LTD holds 81,043 shares of VIR stock, worth $709,936. This represents 0.06% of its overall portfolio holdings.

Number of Shares

81,043

Holding current value

$709,936

% of portfolio

0.06%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$8.6 - $11.9 $696,969 - $964,411	81,043 New	81,043 $820,000
Q3 2023 Nov 13, 2023	SELL	$9.14 - $24.62 $45,955 - $123,789	-5,028 Reduced 25.18%	14,943 $140,000
Q2 2023 Aug 14, 2023	SELL	$23.2 - $27.29 $1.16 Million - $1.36 Million	-50,017 Reduced 71.47%	19,971 $489,000
Q1 2023 May 12, 2023	BUY	$22.26 - $30.85 $383,962 - $532,131	17,249 Added 32.71%	69,988 $1.63 Million
Q4 2022 Feb 14, 2023	SELL	$19.96 - $28.22 $97,863 - $138,362	-4,903 Reduced 8.51%	52,739 $1.33 Million

Q3 2022 Nov 10, 2022	BUY	$18.26 - $31.1 $180,244 - $306,988	9,871 Added 20.66%	57,642 $1.11 Million
Q2 2022 Aug 10, 2022	BUY	$19.08 - $26.7 $618,802 - $865,934	32,432 Added 211.43%	47,771 $1.22 Million
Q1 2022 May 11, 2022	BUY	$21.19 - $40.01 $49,266 - $93,023	2,325 Added 17.87%	15,339 $395,000
Q4 2021 Feb 10, 2022	SELL	$30.97 - $54.03 $22,298 - $38,901	-720 Reduced 5.24%	13,014 $545,000
Q3 2021 Oct 28, 2021	BUY	$34.9 - $54.54 $21,254 - $33,214	609 Added 4.64%	13,734 $598,000
Q2 2021 Aug 10, 2021	BUY	$38.75 - $51.0 $72,656 - $95,625	1,875 Added 16.67%	13,125 $621,000
Q1 2021 Jul 21, 2021	SELL	$26.34 - $83.07 $101,250 - $319,321	-3,844 Reduced 25.47%	11,250 $577,000
Q4 2020 Feb 12, 2021	SELL	$25.51 - $43.38 $945,834 - $1.61 Million	-37,077 Reduced 71.07%	15,094 $404,000
Q3 2020 Oct 30, 2020	BUY	$28.28 - $53.6 $1.48 Million - $2.8 Million	52,171 New	52,171 $1.79 Million

Others Institutions Holding VIR

# of Institutions

225

Shares Held

88.2M

Call Options Held

177K

Put Options Held

182K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.16B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account